tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bryan Brokmeier, 30 are a BUY (93.75%), 2 are a HOLD (6.25%).
Analyst Bryan Brokmeier, carries an average stock price target met ratio of 81.48% that have a potential upside of 68.06% achieved within 526 days. Previously, Bryan Brokmeier worked at CANTOR FITZGERALD.
Bryan Brokmeier’s has documented 55 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TTOO, T2 Biosystms at 03-May-2017.
Analyst best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA).
The best stock recommendation documented was for TTOO (T2 BIOSYSTMS) at 5/3/2017. The price target of $30000 was fulfilled within 133 days with a profit of $10150 (51.13%) receiving and performance score of 3.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-May-2023
$2
$-0.26 (-11.50%)
$1.5
1 months 18 days ago
(15-Dec-2025)
7/7 (100%)
$-0.12 (-5.66%)
12
Hold Since 07-Jan-2022
$2
$-0.26 (-11.50%)
$1.5
2 months 22 days ago
(11-Nov-2025)
11/11 (100%)
$0.14 (7.53%)
150
Buy Since 14-Dec-2023
$2
$-0.26 (-11.50%)
$1.8
2 months 23 days ago
(10-Nov-2025)
3/4 (75%)
$0.25 (14.29%)
150
Buy Since 03-Jun-2024
$3
$0.74 (32.74%)
$4
8 months 24 days ago
(09-May-2025)
1/3 (33.33%)
$1.88 (167.86%)
40
Buy Since 13-Oct-2020
$3
$0.74 (32.74%)
$3
9 months 23 days ago
(10-Apr-2025)
5/13 (38.46%)
$1.62 (117.39%)
123
What Year was the first public recommendation made by Bryan Brokmeier?
